Intraclass correlation coefficients in the Brazilian network for surveillance of severe maternal morbidity study by Samira M Haddad et al.
Haddad et al. BMC Pregnancy and Childbirth 2012, 12:101
http://www.biomedcentral.com/1471-2393/12/101RESEARCH ARTICLE Open AccessIntraclass correlation coefficients in the Brazilian
network for surveillance of severe maternal
morbidity study
Samira M Haddad1, Maria H Sousa2, Jose G Cecatti1,2*, Mary A Parpinelli1, Maria L Costa1, Joao P Souza3
and for the Brazilian Network for Surveillance of Severe Maternal Morbidity GroupAbstract
Background: The purpose of the study was to evaluate intraclass correlation coefficients (ICC) of variables
concerning personal characteristics, structure, outcome and process in the Brazilian Network for Surveillance of
Severe Maternal Morbidity study conducted to identify severe maternal morbidity/near miss cases using the World
Health Organization criteria.
Method: It was a cross-sectional, multicenter study involving 27 hospitals providing care for pregnant women in
Brazil. Cluster size and the mean size of the primary sampling unit were described. Estimated prevalence rates, ICC,
their respective 95% confidence intervals, the design effect and the mean cluster size were presented for each
variable.
Results: Overall, 9,555 cases of severe maternal morbidity (woman admitted with potentially life-threatening
conditions, near miss events or death) were included in the study. ICC ranged from < 0.001 to 0.508, with a median
of 0.035. ICC was < 0.1 for approximately 75% of the variables. For process-related variables, median ICC was 0.09,
with 0.021 for those related to outcome. These findings confirm data from previous studies. Homogeneity may be
considered minor, thus increasing reliability of these findings.
Conclusions: These results may be used to design new cluster trials in maternal and perinatal health and to help
calculate sample sizes.
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healthBackground
Cluster studies are widely used in epidemiological re-
search to evaluate health interventions and implement
public policies. In these cases, selection units or
randomization units consist of population groups (spe-
cific geographical areas) or healthcare units (hospitals)
or healthcare sectors rather than individuals [1,2].
In single-stage cluster sampling, all subjects belonging
to each group are included to obtain data of interest.* Correspondence: cecatti@unicamp.br
1Department of Obstetrics & Gynecology, University of Campinas, R
Alexander Fleming, 101, Campinas, SP 13083-881, Brazil
2Campinas Center for Studies in Reproductive Health (CEMICAMP), Campinas,
SP, Brazil
Full list of author information is available at the end of the article
© 2012 Haddad et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orUnlike simple random sampling (SRS) in which each in-
dividual has an equal likelihood of being selected within
the general population, data obtained from clusters may
not be sufficiently representative to allow for
generalization. This is due to a greater degree of homo-
geneity in characteristics of the population under obser-
vation, as opposed to heterogeneity found in the general
population [2].
Reliability of estimates obtained from studies using
cluster sampling may be analyzed by measuring inter-
and intra-cluster variance. One way to perform these
measurements is to calculate δ, the intraclass correlation
coefficient (ICC), for variables evaluated in the study [3].
Another way to perform measurements is to calculate
the design effect (DEFF).l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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geneity among elements within clusters. The ICC of a
variable indicates to what extent variance of a parameter
can be explained by variation between clusters [4,5]. Its
value depends on the type of variable, cluster size and
prevalence of the condition [6]. Coefficients closest to
zero suggest intraclass heterogeneity, indicating that the
variable is randomly distributed among clusters. Simi-
larly, values close to 1 indicate homogeneity in a sample
and the variance of cluster units is greater than that of
single elements [2].
Design effect (DEFF) indicates the extent to which the
variance of parameter estimate is a result of study de-
sign, in this case the cluster sampling, compared to what
would be obtained if sampling had been carried out by
the SRS method [7]. For example, a DEFF value of 3
indicates that the variance of parameter estimation is
three times greater than would be found if the study had
been based on a random sample of equal size. Compo-
nents involved in calculating the DEFF are ICC and
mean cluster size. The larger the ICC and the larger the
cluster, the higher the DEFF value [8].
The routine adoption of ICC calculation in cluster
studies may improve interpretation of the results and fa-
cilitate the development of new studies in the field.
These values could be used as a correction factor for the
calculation of sample size in future cluster studies, thus
avoiding underestimates, since, in studies in which SRS
is used, the sample size required to achieve sufficient
statistical power is generally smaller [4].
The Brazilian Network for Surveillance of Severe Ma-
ternal Morbidity study was developed with the objective
of identifying cases of severe maternal morbidity/near
miss (woman admitted with potentially life threatening
conditions, near miss) or death in 27 hospitals distribu-
ted throughout Brazil. The participating centers were
selected using the following criteria: the availability of
each center to participate in the surveillance study, the
geographical region of the country in which the hospital
was situated and a requirement that the hospital in
question performed at least 1,000 deliveries per year.
Therefore, the participating centers constituted the pri-
mary sampling units, while the subjects at each center
represented the units of analysis [9].
The objective of the present report is to evaluate the
intraclass correlation coefficients of the variables asso-
ciated with outcome, process, personal characteristics
and structure, based on the data collected by the Brazil-
ian Network for Surveillance of Severe Maternal Mor-
bidity, as well as the design effects.
Methods
The Brazilian Network for Surveillance of Severe Mater-
nal Morbidity, established in 2009, conducted a cross-sectional, multicenter study involving 27 hospitals pro-
viding care for pregnant women in Brazil. The objective
of this network was to identify cases of severe maternal
morbidity/near miss, using the criteria established by the
World Health Organization (WHO) to characterize
these conditions [10]. According to this definition, a ma-
ternal near miss is a woman who experienced a very
serious complication during pregnancy and almost died
but survived at least until the 42nd day of postpartum
period [10].
The selection of clusters was based predominantly on
the location of the hospitals in order to ensure broad
coverage throughout the country, and on a minimum of
1,000 deliveries per center per year to enable the calcu-
lated sample size to be reached. The sample size calcula-
tion was based on an prevalence of 8 cases of near miss
for every 1,000 deliveries [11], a maternal death ratio of
140 for every 100,000 liveborn infants, with confidence
level of 95%, and considering a precision level of 8/1,000
for near miss and 8.5/1,000 for maternal death; it was
added approximately 25% based on the fact that this def-
inition of near miss had not yet been tested. In result,
around 75,000 deliveries would have to be monitored to
identify approximately 600 cases of near miss and 100
maternal deaths. The study was evaluated and approved
locally by the respective Institutional Review Board of
each participating hospital and also by the National
Council for Ethics in Research.
Over the course of one year, all the pregnant women
admitted to these institutions were monitored. Women
found to have any of the morbidity criteria were
included in the analysis. The data of interest to the study
were collected from the women’s charts immediately
after they were discharged from hospital [12]. After data
collection was complete in June 2010, procedures were
initiated to verify and correct any inconsistencies to en-
sure the quality of the data obtained. These procedures
included daily check of all data inputted in the database,
appointment of possible inconsistence to researchers,
correction of errors and programmed check of all data-
set at the end of study.
Data analysis
Initially, the cluster size and the mean size of the pri-
mary sampling unit (PSU) obtained from the total sam-
ple of 9,555 women were described. Estimated
prevalences of each dichotomized variable, intraclass
correlation coefficients (ICC), their respective 95% confi-
dence intervals (95% CI), design effects (DEFF) and
mean cluster size for each variable were calculated. The
software programs used for the analysis were SPSS, ver-
sion 17.0 [13] and Stata, version 7.0 [14], taking into
consideration the cluster sampling plan (centers) for
data analysis. Information on health facilities and live
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data [15,16].
Sampling plan used in the Brazilian network for
surveillance of severe maternal morbidity study
A single-stage cluster sampling was used, with 27 pri-
mary sampling units (PSU) corresponding to the 27 par-
ticipating centers (hospitals). The sampling plan did not
involve stratification of the PSU or weighting of the data.
The unit of analysis (subject) was the registration of each
woman admitted with potentially life threatening condi-
tions, near miss or death.
























yαβ (α for cluster and β for
individual) is the total number of subjects in the sample
possessing a certain category (for example “Yes”) for the
variable yαβ (dichotomized); for example, y: the total
number of subjects in the sample with “prenatal care at
the same facility”, and x ¼
X
α
xα is the size of the avail-
able sample (valid) for that variable, where xα is the sam-
ple size for the cluster ‘α’.










Intraclass correlation coefficient – ICC (Roh)




, where s2a is the variance between clusters;
s2b is the variance within clusters; b is the size of clusters
and s^2 is the estimate of S2: (the variance in individual
level). The estimate s^2is obtained by: s^2 ¼ s2a þ b1b s2b
Stata’s equivalent computing formula [14] is:
ICC ¼ F  1ð Þa=n
1þ F  1ð Þa=n
where ‘F’ is the Snedecor’s F-value from the ANOVA
table and ‘a’ is the number of groups. The varianceestimate for ICC is obtained by an extensive asymptotic
formula, and because this it was not showed.
Design effect - DEFF [2]
Deff ¼ varactual rð Þ




where varactual(r) is the estimated variance according to
the complex design being studied and varSRS(r) is the
variance in the estimator considering the design as if it
were calculated using a SRS of the same size, n.
 Variance estimator of r under the design being
studied:





ra  rð Þ2
a
 Variance estimator of r under SRS:
varSRS rð Þ ¼ r 1 rð Þn 1ð Þ
where r is the ratio estimator under the SRS.
Recalculation of the sample size
Using the ICC from the main outcome as a correction
factor [17]:
n ¼ a=ICC: Deff  1þ ICCð Þ
Where ‘a’ is the number of clusters, ‘Deff ’ the design
effect and ‘ICC’ the intraclass correlation coefficient of
the main outcome.
Results
Of the 82,388 deliveries performed in the participating
institutions during the study period, 82,144 liveborn
infants and 9,555 cases of maternal morbidity were
included in the study. The mean size of each cluster was
354 and the distribution of cases per center and region
and of the liveborn infants per region is shown in
Table 1.
The ICCs ranged from < 0.001 to 0.508, with a median
of 0.035. The ICC was below 0.1 for approximately 75%
of the variables. In this block of variables, the mediann
ICC was 0.021, while in the other 25%, median ICC was
0.195. The ICCs for the variables related to the process
are shown in Table 2, with values ranging from 0.001 to
0.508 (median 0.09), while DEFF values varied from 1.5
to 292.63 (median 20.52).
Table 3 shows the variables related to outcome, with
ICCs that ranged from < 0.001 to 0.375 (median 0.021)
and DEFF values of 0.94 to 289 (median 6.24). ICC
Table 1 Distribution of cases and live births (LB) by

























































Total (n) 27 9555 82,144 2,934,828
Mean cluster size (na)= 354.
#Denominator of the expression of the ratio estimator.
*Data from SINASC (Brazil, 2011) [16].
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ables associated with outcome, while the proportion of
variables for which ICC was < 0.07 was almost 80%.
Tables 4 and 5 show the ICC values with their respect-
ive 95% confidence intervals, prevalence rates, DEFF
values and the mean size of the clusters for the variables
referring to population/obstetric characteristics and
structure, respectively. With the exception of some vari-
ables related to structure, particularly those associated
with delays in the service or healthcare system, ICC
values were very low.
Based on the fact that the sample size calculation did
not take into account the ICC for the primary outcome
of interest, because it was not available from otherstudies at the time of project development, the sample
size was recalculated using the ICC for the variable near
miss/deaths as the correction factor.
This was an exercise to evaluate if our sample would
have been sufficient for analysis considering the cluster
design. This variable was used because it is the main
outcome of interest in this study and its value was 0,077.
Using the formula for recalculating the sample size in
such situations [17], results indicate that a sample size of
7,072 would be needed to identify the near miss/death
cases and it corresponds to 74% of the total number of
subjects included in the Network.
Discussion
The values of the intraclass correlation coefficients
found in this study can be considered low, close to zero,
for the majority of the variables. Intraclass heterogeneity
was greater in the variables related to outcome in com-
parison with the others.
In selecting the clusters, stratification by region was
not performed. Proportionally more of the centers were
situated in the southeast of the country (48%), and con-
sequently a greater number of liveborn infants were also
born in this region (46%). This distribution is in con-
formity with the actual distribution of healthcare institu-
tions and the proportionality of liveborn infants per
region of the country. According to the Ministry of
Health’s National Register of Healthcare Institutions, ap-
proximately 45% of the institutions registered are situ-
ated in the southeastern region [15] and, in 2008, 38.5%
of all liveborn infants were born in this region [16]. Pro-
portionality was also maintained in comparison with the
other regions.
Although the surveillance of cases of severe maternal
morbidity/near miss was prospective, the data were col-
lected from the patients’ charts immediately following
the women’s discharge from hospital. Therefore, for
some variables, the number of individuals for whom data
is available is less than the total number of cases, since it
was impossible to recover some of the missing data. This
possible loss of part of the data for some of the variables
was predicted and taken into consideration in planning
the study. Severely ill women may not be able to consent
to participate in studies of this type because they may be
unconscious, may die or may find themselves in various
different situations of emotional fragility. Therefore, data
collection following hospital discharge was completely
anonymous and avoided the need to obtain informed
consent, what allowed a larger number of research sub-
jects to be included, factors that are important in studies
of serious conditions with a relatively low prevalence
rate.
Previous studies have shown that ICC values are gen-
erally higher for variables related to process compared
Table 2 Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect, and mean
cluster size for variables related to the process
Variable P (%) ICC 95% CI for ICC DEFF na
• Prenatal care at the same institution 22.1 0.103 0.033−0.174 44.72 316
• Access of women to the center (Spontaneous demand) 47.9 0.195 0.078−0.312 118.12 333
• Major type of healthcare insurance used for prenatal care (Public) 88.5 0.115 0.039−0.191 30.27 279
• Major type of healthcare insurance used for hospital admission (Public) 98.9 0.508 0.323−0.693 31.66 354
Procedure related to abortion
• Procedure performed: D&C 77.8 0.054 0.001−0.148 1.50 9
• Procedure performed: Oxytocin 33.3 0.339 0.136−0.542 9.39 9
• Procedure performed: Vacuum aspiration 7.0 0.001 <0.001−0.068 2.26 9
• Procedure performed: Prostaglandins 22.2 0.118 <0.001−0.245 1.91 9
• Procedure performed: Other 7.0 0.155 0.011−0.298 1.53 9
Related to PLTC criteria
• Any therapeutic management 76.1 0.272 0.125−0.419 225.19 354
• Transfusion of blood derivatives 16.4 0.079 0.024−0.133 37.50 354
• Central venous access 3.8 0.090 0.028−0.151 21.23 354
• Admission to ICU 22.1 0.288 0.136−0.439 199.58 354
• Prolonged hospital stay 30.0 0.098 0.032−0.164 81.88 354
• Intubation unrelated to anesthesia 3.1 0.047 0.013−0.081 12.99 354
• Return to operating room 3.3 0.021 0.005−0.038 11.75 354
• Hysterectomy/laparotomy 6.2 0.043 0.011−0.074 20.44 354
• Use of magnesium sulfate 48.3 0.363 0.192−0.534 292.63 354
• Another major surgical procedure 0.8 0.008 0.001−0.016 6.35 354
Related to near miss criteria
• Any management near miss criteria 6.1 0.075 0.023–0.127 20.52 354
• Continuous use of vasoactive drug 2.6 0.028 0.007–0.049 8.93 354
• Hysterectomy due to infection or hemorrhage 1.8 0.031 0.008–0.054 8.05 354
• Transfusion of ≥5 U red cells 2.6 0.053 0.015–0.091 11.42 354
• Intubation and ventilation ≥ 60 min unrelated to anesthesia 3.1 0.047 0.013–0.082 13.94 354
• Dialysis for acute renal failure 0.7 0.009 0.001−0.017 3.60 354
• Cardiopulmonary resuscitation (CPR) 1.3 0.018 0.004–0.033 8.41 354
• At least one of these conditions was already present when the woman was admitted 32.0 0.132 0.046–0.218 6.91 34
Related to delay in care
• Delay related to patients and/or their family members (Yes/No) 39.3 0.090 0.028−0151 27.26 310
• Search for a health service 5.3 0.174 0.067–0.281 54.03 310
• Geographic difficulty in accessing health service 2.4 0.352 0.183–0.520 113.16 310
• Refused treatment/care 5.1 0.014 0.002–0.025 7.72 310
• Prenatal care absent or inadequate 32.1 0.043 0.012–0.075 14.98 310
• Delay in care related with health professional 17.3 0.328 0.164−0.492 134.27 331
• Delay in diagnosis 5.5 0.218 0.091–0.346 72.81 331
• Delay in starting treatment 6.7 0.321 0.159–0.483 105.23 331
• Inadequate management 13.6 0.300 0.144–0.456 121.82 331
• Delay in referring or transferring the case 3.3 0.055 0.015–0.095 20.77 331
P: Prevalence of each category; ICC: Intraclass Correlation Coefficient; 95% CI: 95% confidence interval; DEFF: Design effect; na: Mean cluster size; PLTC: Potentially
life-threatening condition; NM: Near miss.
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Table 3 Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect and mean
cluster size for variables related to outcome
Variable P (%) ICC 95% CI for ICC DEFF na
• Any hemorrhagic complication 24.8 0.165 0.062−0.268 129.54 354
• Abruptio placentae 5.7 0.016 0.003−0.029 9.55 354
• Placenta previa/acreta 2.2 0.017 0.004−0.031 6.24 354
• Complicated ectopic pregnancy 3.1 0.034 0.009−0.059 17.72 354
• Uterine rupture 0.3 0.005 <0.001−0.011 2.12 354
• Severe post abortion hemorrhage 1.3 0.015 0.003−0.028 5.92 354
• Postpartum hemorrhage 12.5 0.248 0.110−0.387 200.97 354
✓ Atony 63.0 0.375 0.134−0.617 77.37 44
✓ Retained placenta 11.8 0.114 0.005−0.224 12.94 44
✓ Tears 8.8 0.130 0.008−0.251 10.04 44
✓ Coagulopathy 4.6 0.102 0.002−0.203 13.51 44
✓ Uterine inversion 0.6 0.035 <0.001−0.079 1.65 44
✓ Other obstetric cause 11.2 0.370 0.130−0.610 43.77 44
• Other severe hemorrhage 1.0 0.023 0.005−0.041 6.16 354
• Any complication due to hypertension 70.2 0.183 0.072−0.294 124.72 354
• Severe preeclampsia 51.2 0.231 0.099−0.363 188.23 354
• Eclampsia 4.5 0.023 0.005−0.040 14.62 354
• Severe hypertension 18.3 0.334 0.169−0.499 289.00 354
• HELLP syndrome 6.2 0.028 0.007−0.049 15.43 354
• Acute fatty liver 0.2 0.005 0.001−0.010 1.59 354
• Any other complication 17.2 0.103 0.034−0.172 31.93 354
• Pulmonary edema 1.7 0.020 0.004−0.036 4.45 354
• Seizures 1.4 0.009 0.001−0.016 3.66 354
• Thrombocytopenia 3.9 0.022 0.005−0.039 6.77 354
 Thyrotoxic crises 0.1 0.007 0.001−0.013 1.55 354
• Shock 3.1 0.034 0.009−0.059 9.95 354
• Acute respiratory failure 4.0 0.051 0.014−0.087 19.37 354
• Acidosis 1.6 0.021 0.005−0.038 12.54 354
• Cardiopathy 1.7 0.013 0.002−0.023 5.71 354
• Stroke 0.2 0.001 0.001−0.003 1.10 354
• Coagulation defects 2.0 0.012 0.002−0.021 4.69 354
• Disseminated intravascular coagulation 0.6 0.012 0.002−0.021 2.60 354
• Thromboembolism 0.9 0.010 0.001−0.018 4.95 354
• Diabetic ketoacidosis 0.2 0.004 0.001−0.008 0.94 354
• Jaundice/liver dysfunction 1.4 0.014 0.003−0.026 2.46 354
• Meningitis <0.1 <0.001 0.001−0.002 0.94 354
• Severe sepsis 3.5 0.064 0.019−0.109 18.09 354
✓ Postpartum endometritis 19.5 0.131 0.011−0.252 3.95 13
✓ Post abortion endometritis 11.0 0.043 0.001−0.115 2.13 13
✓ Pulmonary focus 29.3 0.055 0.001−0.133 2.03 13
✓ Urinary focus 25.0 0.013 0.001−0.067 1.08 13
✓Other 15.2 0.042 0.001−0.113 1.15 13
• Acute renal failure 2.2 0.027 0.006−0.047 8.68 354
• Complication possibly associated with Influenza A ‘H1N1’ 2.2 0.056 0.016−0.097 20.62 354
• Any clinical maternal near miss criteria 5.5 0.037 0.010−0.065 15.44 354
• Cyanosis 1.3 0.023 0.005−0.040 12.63 354
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Table 3 Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect and mean
cluster size for variables related to outcome (Continued)
• Gasping 0.4 0.009 0.001−0.017 4.21 354
• Respiratory rate <6 or RR>40 2.0 0.016 0.003−0.029 8.42 354
• Shock 2.6 0.031 0.008−0.054 9.24 354
• Oliguria unresponsive to fluids or diuretics 0.9 0.010 0.001−0.018 4.43 354
• Coagulation problems 1.0 0.012 0.002−0.021 4.88 354
• Loss of consciousness for 12h or more 0.7 0.005 <0.001−0.010 4.25 354
• Absence of consciousness and absence of pulse rate/heartbeat 0.7 0.006 0.001−0.011 4.96 354
• Stroke 0.3 0.002 0.001−0.005 1.16 354
• Uncontrolled seizures – total paralysis 0.2 0.001 <0.001−0.004 2.22 354
• Jaundice in presence of preeclampsia 0.3 0.001 <0.001−0.002 1.36 354
• Any laboratory near miss criteria 5.2 0.047 0.013−0.082 12.08 354
• O2 saturation < 90% for longer than 60 min 1.9 0.016 0.003−0.029 8.30 354
• PaO2/FiO2 < 200 (Yes/No) 1.1 0.015 0.003−0.028 8.37 354
• Creatinine ≥ 300 mmol/l or ≥ 3.5 mg/dl 1.0 0.007 0.001−0.013 3.03 354
• Bilirubin ≥ 100 mmol/l or ≥ 6 mg/dl 0.5 <0.001 <0.001−0.002 1.25 354
• pH < 7.1 0.8 0.009 0.001−0.016 5.32 354
• Lactate > 5 0.8 0.098 0.032−0.165 18.31 354
• Platelet < 50,000 2.1 0.025 0.006−0.044 5.32 354
• Absence of consciousness plus glucose and ketoacids in urine 0.2 0.004 <0.001−0.009 3.49 354
• Condition of woman at discharge (Medical discharge) 94.1 0.011 0.002–0.020 6.54 354
• Unsafe abortion 0.6 0.025 0.006–0.045 7.43 310
• Maternal Death 1.5 0.018 0.004−0.033 7.93 354
• Maternal Death + NM 9.5 0.077 0.023−0.130 21.09 354
P: Prevalence of each category; ICC: Intraclass Correlation Coefficient; 95% CI: 95% confidence interval; DEFF: Design effect; na: Mean cluster size; NM: Near miss.
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same intervention (measure of process), responses may
differ between the different individuals under thera-
peutic management (outcome measurement). Further-
more, higher healthcare levels tend to increase the
degree of homogeneity [17-20]. The explanation for this
is that when the level of care is higher, there is a greater
likelihood that management techniques will be standar-
dized and institutional protocols will be used. In these
cases, when one of the objectives is to evaluate compli-
ance with established guidelines, homogeneity may be
interpreted as a leveling of institutions with respect to
certain recommendations.
This tendency is also seen in the present results, which
were obtained from secondary and tertiary care hospi-
tals, the majority of which were teaching hospitals. In
this type of institution, the majority of procedures are
performed in conformity with evidence-based healthcare
protocols. Indeed, the mean ICC value for the variables
related to process was 2.6 times higher than the mean
ICC value for the variables related to outcome.
The variable with the highest ICC was “Major type of
healthcare insurance used for hospital admission” with a
value of 0.508. This homogeneity was expected, sinceonly 3 of the 27 centers accepted private patients, all the
other centers being exclusively public healthcare services.
Some of the variables related to process were obtained
from a specific section of the study focusing on delays
during patient care. In addition to obtaining data from
the women’s charts, this study also involved another step
in which the investigators were instructed to make a
subjective analysis of the chain of healthcare services
provided, based on the data available on the charts. In
addition, after all the variables had been completed, the
data for each subject were reanalyzed by the principal
investigators and standard procedures for the classifica-
tion of delays were implemented for all the cases in all
the clusters. Therefore, the greater homogeneity found
for these variables may be explained by this “standard
correction” adopted for all the centers.
Previous studies in the primary care sector have
reported ICC values < 0.05 for variables related to out-
come and ICC values > 0.05 for variables related to the
process [20]. In the field of maternal and perinatal
healthcare, Taljaard et al. calculated ICC values based on
data obtained from secondary/tertiary services [18]. The
ICC of some variables analyzed in this study can be
compared with ours as reported in Table 6.
Table 4 Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect and the mean
cluster size with respect to personal and obstetric data
Variable P (%) ICC 95% CI for ICC DEFF na
• Age (<30 years) 65.6 0.013 0.002−0.024 4.00 354
• Skin color (White) 42.5 0.285 0.127−0.443 146.55 264
• Schooling (Primary) 46.5 0.051 0.012−0.091 17.45 256
• Marital status (Has a partner) 53.2 0.176 0.066−0.286 101.96 298
• Weight (<75 kg) 52.3 0.055 0.010−0.101 21.45 167
• Height (<1.60 m) 48.6 0.054 0.007−0.101 13.51 151
• Body Mass Index (Low BMI) 15.4 0.053 0.006−0.100 18.47 146
• Number of pregnancies (One) 41.9 0.010 0.001−0.019 9.01 352
• Number of deliveries (None) 48.2 0.010 0.002−0.019 8.87 352
• Number of abortions (None) 77.6 0.005 <0.001−0.011 2.59 352
• Number of previous C-sections (None) 76.0 0.011 0.002−0.021 6.87 347
• Number of live births (None) 51.3 0.016 0.003−0.028 11.27 341
• Time since last delivery (≤2 years) 25.5 0.022 0.001−0.043 4.23 99
• Previous uterine surgery 2.0 0.067 0.017−0.117 20.52 299
• Number of prenatal visits (<6) 46.4 0.018 0.003−0.034 5.34 276
• Pregnant at admission 95.0 0.043 0.011−0.074 20.70 354
• Gestational age at admission (<37 weeks) 53.4 0.069 0.020−0.117 37.71 327
• Mode of onset of labor (no labor) 49.4 0.113 0.038−0.188 88.44 349
• Gestational age at resolution (<37 weeks) 45.7 0.055 0.015−0.095 31.28 309
• Mode of delivery (C-section before labor) 49.6 0.111 0.037−0.184 87.28 352
• Mode of onset of abortion (Spontaneous) 63.6 0.044 <0.001−0.141 1.52 8
• Total number of fetuses (None) 6.0 0.128 0.044−0.212 52.87 325
• Fetal presentation at birth (Cephalic) 91.3 0.011 0.001−0.020 4.77 273
• Some pathological or risky condition prior to this current pregnancy 48.9 0.115 0.038−0.191 47.12 305
• Chronic hypertension 17.7 0.046 0.012−0.079 15.98 305
• Obesity 24.1 0.110 0.036−0.184 65.40 305
• Low weight 0.3 0.004 <0.001−0.008 1.68 305
• Diabetes mellitus 2.5 0.023 0.005−0.041 7.84 305
• Smoking 5.7 0.065 0.018−0.111 44.05 305
• Cardiac diseases 2.9 0.025 0.006−0.045 9.23 305
• Respiratory diseases 2.8 0.018 0.004−0.033 9.67 305
• Renal diseases 1.2 0.038 0.010−0.067 11.74 305
• Sickle cell disease-thalassemia 0.8 0.005 <0.001−0.011 5.08 305
• HIV/AIDS 1.1 0.006 <0.001−0.013 3.16 305
• Thyroid disease 1.4 0.008 0.001−0.016 2.65 305
• Neurologic diseases/epilepsy 1.2 0.011 0.001−0.020 4.35 305
• Collagenosis 0.6 0.028 0.007−0.050 8.93 305
• Cancer 0.3 0.006 <0.001−0.012 2.31 305
• Other 5.2 0.037 0.009−0.065 13.99 305
• Drug addiction 1.2 0.005 <0.001−0.010 4.07 305
P: prevalence of each category; ICC: Intraclass Correlation Coefficient; 95% CI: 95% confidence interval; DEFF: Design effect; na: Mean cluster size.
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eral, ICC values for the variables related to the process
tended to be > 0.07, with values < 0.07 for the variables
related to outcome. The present findings are in agreement
with this observation. Furthermore, these values canprobably be considered as a good parameter of variance
for calculating sample size in new studies in this area,
similar to the 0.08 value used by van de Ven et al. [21].
Pagel et al. [22] estimated ICC of data from five
community-based cluster-randomized controlled trials,
Table 5 Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect and mean
cluster size with respect to the variables related to structure
Variable P (%) ICC 95% CI for ICC DEFF na
• Delay related to service or healthcare system 15.6 0.247 0.108−0.387 106.64 328
• Lack of medication 1.3 0.021 0.005–0.038 9.77 328
• Difficulties with municipal/hospital transport 1.3 0.031 0.007–0.055 9.27 328
• Difficulties with communication (hospital/central regulation) 8.8 0.206 0.083–0.329 99.07 328
• Lack of blood derivatives 0.6 0.014 0.002–0.025 8.17 328
• Difficulty related to monitoring (intensive care unit) 4.6 0.230 0.097–0.363 64.99 328
• Lack of trained personnel 3.1 0.063 0.018–0.107 24.25 328
• Difficulty related to access to prenatal care 1.4 0.084 0.025–0.142 20.09 328
P: Prevalence of each category; ICC: Intraclass Correlation Coefficient; 95% CI: 95% confidence interval; DEFF: Design effect; na: Mean cluster size.
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ternal and newborn health outcomes. The mean cluster
size of these studies ranged from 3,934 to 27,953 people.
Of 9 key perinatal indicators, only maternal death has
the possibility of comparison with our calculations and
its ICC ranged from 0.00 to 0.00051.
All those comparisons show what was already known.
The smaller the cluster size, the higher the ICC, and the
opposite occurs regarding the prevalence of the condi-
tion. Mortality events are rare in community based
population and the prevalence rises with morbidity asso-
ciation. Pagel et al. [22] established as a limitation of
their findings that the ICC estimates for rare outcomes
as maternal mortality are not likely to be reliable.
Taljaard et al. [18] collected data from hospital based
population, as our study, and obtained ICC similar to
our findings.
This study is based on pregnant women who had at
least one of the potentially life threatening conditions.
So, prevalence of any factor that is associated with these
conditions will be higher in the study sample than in the
general obstetric population. This could potentially in-
flate ICC estimation as ICC generally tends to increase
with higher prevalence. The ICCs of this study also de-
pend on other factors such as the hospitals’ characteris-
tics. Caution in applying these ICCs to other settingsTable 6 Comparisom of Intraclass Correlation Coefficients
of some variables between this study and study by
Taljaard et al. [18]
Variable Haddad et al. Taljaard et al.
ICC na ICC na
• HIV positive 0.006 305 0.022 865
• Chronic respiratory conditions 0.018 305 0.042 861
• Diabetes mellitus 0.023 305 0.010 862
• Hysterectomy 0.031 354 0.002 862
• Eclampsia 0.023 354 0.007 862
• Maternal Death 0.018 354 0.0003 866
ICC: Intraclass Correlation Coefficient; na: Mean cluster size.should be used and this could be considered as a pos-
sible limitation of the study.
The absence of previous studies using these new near
miss criteria standardized by the WHO [10] made it im-
possible to obtain the respective ICC values for the vari-
ables of interest related to outcome. Therefore, in this
study sample size was calculated based exclusively on
previous prevalence rates of the condition.
Considering the mean general characteristics of
women in this study, most of whom received care in
public hospitals linked to universities, and that the ICC
values showed sample heterogeneity, studies conducted
in middle income countries with similar characteristics
to Brazil probably can use the ICC values of this study
as the basis for their calculations.
Conclusions
The Brazilian Network for Surveillance of Severe Mater-
nal Morbidity conducted a pioneering, cross sectional,
multicenter study on the application of the new WHO
near miss criteria to identify severe cases in obstetrics.
This paper reports the intraclass correlation coefficients
for study variables. The results found are in agreement
with those of previous studies and homogeneity of the
data obtained from variables related to outcome may be
considered minor (median ICC 0.021), increasing reli-
ability of the study estimates. These values may be used
to plan new cluster studies in maternal and perinatal
health, mainly studies associated with severe maternal
morbidity/near miss events. They may be useful for sam-
ple size calculation.
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